Scientific Content

Charting New Course: The Frontier of Early Intervention and Disease Modification in AD

Early Intervention and Disease Modification in Atopic Dermatitis

Saudi Health Promotion and Prevention Guideline for Diabetes Mellitus

RSV Shield: WEQAYA's Strategy on Nirsevimab Implementation

This video explains WEQAYA's strategy on Nirsevimab Implementation

Guidelines for RSV prevention with Nirsevimab

Respiratory Syncytial Virus (RSV) is a major cause of lower respiratory tract infections in infants and young children. Nirsevimab is a long-acting monoclonal antibody that provides passive immunization against RSV, offering protection throughout the RSV season with a single dose

An easy guide to use Nirsevimab

Type II Summit 2025

Video Showcasing the Type II Summit 2025

World Epilepsy Day Podcast Ep. 3

World Epilepsy Day Podcast Ep. 2